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ABSTRACT 
 We evaluated the usefulness of PCR analysis of the 16S-23S rRNA gene internal 
transcribed spacer (ITS) and CTX-M extended-spectrum β-lactamase (ESBL) followed 
by microchip gel electrophoresis (MGE) for direct identification and CTX-M detection of 
Gram-negative bacteria (GNB) from positive blood culture bottles. Of 251 GNB isolated 
from blood cultures containing a single bacterium, 225 (90%) were correctly identified at 
the species level directly from positive blood culture bottles by comparing the ITS-PCR 
patterns of the sample strain with those of the control strains. There were no cases of 
incorrect identification. Limitations encountered included the inability to detect mixed 
cultures (four bottles) as well as some species (Enterobacter species and Klebsiella 
oxytoca) demonstrating identical ITS-PCR patterns. One hundred nine ESBL-producing 
isolates from various clinical materials between January 2005 and December 2008 were 
examined for blaCTX-M, blaSHV, and blaTEM genes by PCR and sequences of PCR products. 
CTX-M ESBL was detected from 105 isolates and SHV ESBL from two isolates. The 
remaining two isolates (K. oxytoca) were shown to harbor blaOXY. Twenty (19%) of 104 
Escherichia coli isolates from blood cultures were suspected to produce ESBL by the 
combination disk method, and these isolates were shown to harbor CTX-M ESBL by 
PCR-MGE. The results were obtained within 1.5 h at a calculated cost of $6.50 per 
specimen. In conclusion, simultaneous detection of ITS length polymorphisms and 
blaCTX-M by single PCR followed by MGE is useful for rapid, cost-effective, and reliable 





Bloodstream infections are a major cause of morbidity and mortality. Traditional 
identification of blood culture isolates requires subculture and overnight incubation to 
obtain isolated colonies. Rapid methods to differentiate bacteria directly from positive 
blood cultures have been developed (7, 8, 14), thus reducing the turnaround time 
compared to traditional testing. Rapid identification can significantly improve outcome 
in infected patients by enabling rapid and appropriate antimicrobial therapy, leading to 
a decrease in mortality, shortened hospital stay, and lower hospitalization costs (3).       
 Several nucleic acid-based approaches have proven useful for identifying many 
microorganisms and are becoming more commonplace in the clinical microbiology 
laboratory (14, 21). Spacer regions separating the two prokaryotic rRNA genes are 
characterized by a high degree of sequence and length variation at both the genus and 
species levels (5, 8, 10, 13). The aim of the present study was to establish a rapid and 
accurate method for the identification of GNB from isolated colonies, as well as positive 
blood culture bottles with positive signals, by PCR amplification of the 16S-23S rRNA 
gene spacer region. As for rapid sizing of PCR products, Turenne et al (25) used a 
capillary electrophoresis system which needs less than 30 min for analysis. Recently, 
electrophoretic analysis with a microchip was developed (6). To determine the length of 
PCR products more rapidly, we used a microchip gel electrophoresis (MGE) instrument. 
This instrument detects PCR products within 5 min, whereas agar gel electrophoresis 
used in our study needed 2 h to determine the length of PCR amplicons. The former has 
enabled us to generate a profile of the expected amplicon sizes for a broad range of 
bacteria. The advantages of using such an instrument include speed and elimination of 
slab gels and staining steps as well as of species-specific probes or DNA sequencing. 
Furthermore, minimal manual labor is required, thus making the fragment detection 
system accurate and cost-effective. 
  Earlier studies have shown that antimicrobial susceptibility testing does not 
significantly influence a physician’s choice of appropriate antimicrobial therapy (18). 
However, with advances in technology PCR-based detection of mecA and van directly 
from positive blood culture bottles is now available (7). On the other hand, 
ESBL-producing strains, especially CTX-M ESBL-producing strains, are increasing 
worldwide (4, 9, 11, 15, 23). Although ESBLs are inactivated with β-lactamase 
inhibitors, ESBL-producing strains may be resistant to third- to fourth generation 
cephalosporins such as cefotaxime, ceftazidime and cefepime. Therefore, antibiotic 
options in the treatment of ESBL-producing organisms are limited (11, 24). In addition 
to rapid species identification of microorganisms, detection of the CTX-M gene in blood 
culture bottles was simultaneously examined by single PCR in the present study.  
 
MATERIALS AND METHODS 
Bacterial strains. A total of 329 GNB (given the prefix K) isolated from clinical 
samples between January 2005 and December 2007 at Kanazawa University Hospital 
and 39 reference strains were used to determine the internal transcribed spacer PCR 
patterns (ITS-PCR). The reference strains were obtained from the American Type 
Culture Collection (ATCC) (Manassas, VA), NITE Biological Resource Center (NBRC) 
(Tokyo, Japan), Laboratory Culture Collection (IID) (University of Tokyo, Tokyo, Japan), 
and the Japan Collection of Microorganisms (JCM) (Wako, Japan) (Table 1). In addition, 
isolates of clinically relevant species not included in the reference strains were selected 
from the isolates from our laboratory, and used as controls. When two or more ITS-PCR 
patterns were found among the same species, a strain isolated at Kanazawa University 
Hospital was selected randomly from each group of ITS-PCR pattern and was also used 
as a control.  
A total of 255 blood culture bottles (259 isolates) that gave positive results on testing 
for GNB from January 2007 to December 2009 were used for molecular identification of 
bacteria by ITS-PCR and for detection of CTX-M ESBL by PCR. Our laboratory uses the 
BacT/ALERT 3D blood culture system (bioMérieux Inc., Durham, NC) with SA aerobic 
and SN anaerobic bottles. For each positive blood culture, 5% sheep blood agar, 
Drigalski agar, and Brucella HK agar (only for isolation of anaerobes) were inoculated 
with a drop of broth for isolation. All strains were identified by colony morphology, 
Gram stain characteristics, oxidase test, and by using commercially available kits, such 
as API 20E (bioMérieux) for Enterobacteriaceae, ID test NF-18 (Nissui Pharmaceutical 
Co., Ltd., Tokyo, Japan) for glucose non-fermenting GNB, and ID test HN-20 (Nissui) for 
Haemophilus and Neisseria species. The Bacteroides fragilis group was identified 
presumptively by growth on both Bacteroides agar plate (Nissui) and Bacteroides bile 
esculin agar plate (Kyokuto Pharmaceutical Ind., Co., Ltd., Tokyo), and Fusobacterium 
species by growth on a modified FM agar plate (Nissui). 
 
 DNA preparation.  
  A colony grown on modified Drigalski agar was suspended in 0.2 ml of TE buffer (10 
mM Tris-HCl, 1 mM EDTA, pH 8.0) at a density equivalent to a 0.5 McFarland standard. 
Aliquots of 2 μl of proteinase K solution (20 mg/ml) (Takara Shuzo Co., Ltd., Ohtsu, 
Japan) were added, followed by incubation at 60°C for 5 min. After 7 min of incubation 
in a boiling water bath, the lysate was centrifuged at 9,000 × g for 2 min, and the 
supernatant was used as the template DNA. Processing of positive blood culture bottles 
for PCR was performed as described previously (8) with slight modifications. Briefly, 
~10 ml of 0.1% sodium dodecyl sulfate was added to 0.1 to 0.2 ml of blood culture fluids, 
and the mixtures were centrifuged at 4,000 × g for 10 min. The pellets were suspended 
in 1.5 ml of distilled water and centrifuged again at 9000 × g for 1 min. Then, 0.1 ml of 
TE buffer and 2 μl of proteinase K solution were added to the pellet, and the mixture 
was incubated at 60°C for 5 min. After 7 min of incubation in a boiling water bath, the 
lysate was centrifuged at 9,000 × g for 2 min, and the supernatant was used as the 
template DNA. DNA was extracted from isolated colonies in ~20 min and that from 
GNB-positive blood culture bottles was obtained in ~30 min.  
 
Identification of GNB by ITS-PCR.  
ITS-PCR was performed using the bacterium-specific universal primers IX 
(5'-GGTGAAGTCGTAACAAG-3') and II (5'-TGCCAAGGCATCCACC-3') (8). PCR 
was performed with 1.5 μl of the template DNA in a total reaction volume of 30 μl 
consisting of 0.75 U of Z-Taq DNA polymerase (Takara Bio Inc., Shiga, Japan), 
0.1μM each primer, 0.2 mM each deoxynucleoside triphosphate, and 3 mM MgCl2. 
Reactions were run in a thermocycler (Biometra Co., Göttingen, Germany). The PCR 
program consisted of 95°C for 10 s (first cycle only), 99°C for 8 s, 52°C for 12 s, 72°C 
for 20 s (25 cycles), and a final extension step at 72°C for 5 min. The ESBL genes 
were also amplified by PCR. The PCR products were separated with MGE 
instrument (model SV1200; Hitachi Electronics Engineering Co., Ltd., Tokyo, Japan) 
as described previously (8). Briefly, a mixture of 9 μl of PCR product and 1μl of 
loading buffer containing the internal standards was loaded into one of the sample 
wells of the microchip, and the mixture was run for 5 min. The mixture of ITS-PCR 
and CTX-M PCR products was applied to MGE, and the electrophoresis patterns 
were analyzed. The database for ITS-PCR patterns of GNB was constructed by using 
commercially available database soft, File Maker Pro (FileMaker Inc. Santa Clara, 
CA). When one to five sizes of PCR products in the order from shorter one were input 
into the database, the names of organism which showed the similar ITS-PCR 
patterns with test strain was shown automatically and the ITS-PCR pattern of the 
test strain was compared visually with those of the control strains on the computer 
screen. Identification was assigned to those isolates with ITS-PCR patterns that 
matched any of the control strains. The PCR procedure required ~40 min, and MGE 
took ~5 min. Therefore, the overall turnaround time of the PCR-MGE was ~1.5 h 
with positive blood culture bottles. 
 
Detection of ESBLs.  
One hundred sixteen of 2,216 Enterobacteriaceae strains isolated from various clinical 
samples between January 2005 and December 2008 were shown to be insusceptible 
(intermediate or resistant) to cefotaxime, cefoperazone, or ceftazidime by the disk 
diffusion method. These antibiotic-nonsusceptible isolates were further subjected to 
analysis for ESBLs. Phenotypic test for ESBL production was performed according to 
the Clinical and Laboratory Standards Institute (CLSI) recommended method using 
combination disks (19). The disks used were cefotaxime, cefpodoxime, and ceftazidime 
disks with and without clavulanate (Eiken Chemical Co., Ltd., Tokyo). Klebsiella 
pneumoniae ATCC 70063 was used as a control SHV ESBL-positive strain, and 
Escherichia coli ATCC 35218 was used as a blaTEM-1-positive strain. Fifty-three 
ESBL-non-producing Enterobacteriaceae strains isolated in our laboratory were also 
used as negative controls. PCR was performed under the same conditions as described 
for ITS-PCR. The primers of CTX-F (5'-ATTCCRGGCGAYCCGCGTGATACC-3') and 
CTX-R (5'-ACCGCGATATCGTTGGTG GTGCCAT-3') used to detect CTX-M ESBLs were 
developed in our laboratory. The isolates were also examined for SHV and TEM ESBLs 
by PCR amplification and sequencing with the primer pairs described previously (2). 
The CTX-M ESBL type was determined by sequence analysis using the primer pairs (1). 
The sequences were determined by direct sequencing of PCR products, and sequencing 
was performed on an ABI Prism 3130 Genetic Analyzer (Applied Biosystems Japan 
Ltd., Tokyo). 
   
RESULTS 
 ITS-PCR patterns of GNB.  
  MGE analysis of the amplified products obtained from 368 isolates comprising 45 
GNB species consistently showed one to four intense and sharp bands (major 
fragments) for each sample, ranging from 241 to 1,765 bp (Table 1). A single fragment of 
the same size (685  ±  6 bp) was obtained from A. calcoaceticus JCM6842T and A. 
baumannii JCM6841T. Two ITS-PCR patterns were observed among Achromobacter 
xylosoxidans, K. pneumoniae, Proteus mirabilis, Providencia rettgeri, Pseudomonas 
putida, and Stenotrophomonas maltophilia; three patterns among B. fragilis group, 
Enterobacter cloacae, and Morganella morganii, and four patterns among Serratia 
marcescens. Nine Salmonella isolates belonging to six serotypes showed common strong 
bands at 449 and 624 bp, and one weak band at 512 bp. There were no significant 
differences among Salmonella serotype isolates. Although most of the strains studied 
had unique ITS-PCR patterns at the species level, identical ITS-PCR patterns were 
found among Enterobacter aerogenes isolates, some E. cloacae strains, and Klebsiella 
oxytoca isolates. In addition, Pseudomonas stutzeri and Ralstonia pickettii yielded a 
single fragment ranging from 591 ±3 and 594 ± bp, respectively. For A. xylosoxidans, 
two ITS-PCR patterns were observed; type axy1 from A. xylosoxidans subspecies 
denitrificans JCM 5490T and type axy2 from A. xylosoxidans subspecies xylosoxidans 
JCM 9659T. Figure 1A shows the seven representative ITS-PCR patterns of clinically 
relevant GNB.  
 
ESBL-producing isolates.  
  Of 116 isolates that were intermediate or resistant to the third-generation 
cephalosporins, 109 were suspected as ESBL-producers by the combination disk method. 
One hundred seven isolates (97 E. coli, 5 K. pneumoniae, 2 K. oxytoca, and 3 Proteus 
mirabilis) were positive for CTX-M genes, the remaining two for SHV-12 ESBL (1 
isolate each E. coli and K. oxytoca). Of 107 CTX-M-positive isolates determined by PCR, 
89 (83%) isolates appeared to carry gene of CTX-M-9, seven of CTX-M-15, three each of 
CTX-M-2 and CTX-M-14, two of CTX-M-3, and one of CTX-M-27. Two CTX-M-positive K. 
oxytoca isolates were shown to harbor the blaOXY gene by sequencing analysis of CTX-M 
gene amplification products. No isolates harboring TEM ESBL genes were found among 
those tested, and there were no cases of false-positive results. Overall, 98 (92%) of 107 
ESBL-producing isolates were E. coli. 
 
Identification of GNB from positive blood culture bottles. 
  A total of 259 bacteria were isolated from 255 GNB-positive blood cultures; 251 
bottles (98%) contained a single bacterial species, while 4 (2%) contained polymicrobial 
growth. ITS-PCR analyses accurately identified 225/259 (87%) of organisms in positive 
blood culture bottles to the species level, while 22 isolates that showed ITS-PCR pattern 
of K. oxytoca were identified as Enterobacter/K. oxytoca group (Table 2). Four isolates 
(three Bacteroides fragilis group and one Acinetobacter lwoffii) were not identified, 
because they showed novel ITS-PCR patterns that were not included in our database. 
Furthermore, eight organisms in mixed culture bottles were not identified because of 
complex ITS-PCR patterns. Overall, 228 (91%) of 251 GNB isolated from bottles that 
contained a single bacterial species were correctly identified at the species level directly 
from blood culture bottles. There were no cases of incorrect identification. CTX-M ESBL 
genes were detected from 20 bottles by PCR, and all ESBL-positive strains were 
identified as E. coli by ITS-PCR patterns and the culture-based method. Figure 1B 
shows the amplification product of the CTX-M ESBL gene and ITS-PCR pattern of 
CTX-M ESBL-producing E. coli.  
Cost analysis was performed for reagents for conventional testing and molecular 
testing. The average cost for conventional identification of GNB ranged from $10 to $12. 
With molecular testing, testing cost is significantly lower when more than one test is 
processed at the same time. The cost of identifying GNB and detecting CTX-M ESBL 
from one sample alone would represent the maximum cost per sample, which was 
calculated to be $6.50. We have calculated the cost of running two samples for 
identification to be $4.80 per sample.  
 
DISCUSSION 
  The PCR assay to detect polymorphisms in the 16S-23S rRNA gene spacer region is 
potentially useful for both species-level identification of coagulase-negative 
Staphylococcus species and GNB (8, 13) and strain discrimination of S. aureus (8) and 
Clostridium difficile (5). One issue that is critical for the successful detection of spacer 
variation is the choice of PCR primers. Primers were selected to target highly conserved 
regions in the 16S and 23S rRNA genes. To date, four primers in the 16S rRNA gene, 
and six primers in the 23S rRNA gene have been proposed, and some primers failed to 
detect spacer variation at the species or strain level (10). Jensen et al. (13) first 
demonstrated that PCR- amplified rDNA spacer polymorphisms using primers G1 
(positions 1,491 – 1,504 based on the sequence of the E. coli 16S rRNA gene) and L1 
(positions 21 – 35 based on the sequence of the E. coli 23S rRNA gene) were useful for 
identification of GNB. We used similar primers IX and II targeting positions 1487 – 
1503 of the E. coli 16S rRNA gene, and positions 23 – 38 of the E. coli 23S rRNA gene, 
respectively. Based on the results obtained with the 368 strains tested here, length 
polymorphisms of the ITS region showed significant promise for identification of 
clinically relevant GNB.  
 It is not surprising that some strains belonging to different genera or species showed 
similar ITS-PCR patterns. In this study, Enterobacter species and K. oxytoca showed 
the same patterns. As these two species have been reported to show similar 
antibiotic-susceptibility patterns (more than 10% strains are resistant to piperacillin, 
third-generation cephalosporins, and tobramycin) (26), rapid species-level identification 
of these species may not be required for planning of antibiotic treatment. When isolates 
tested yielded a single band of similar length, ITS-PCR patterns alone could not be used 
for general differentiation of glucose non-fermenting GNB. For example, P. stutzeri and 
R. pickettii (591  –  594 bp), and Pseudomonas alcaligenes and Pseudomonas 
pseudoalcaligenes (576 – 606 bp) showed bands of similar sizes. Although these four 
species strains are rarely isolated from blood cultures, as shown here and in a previous 
study (14), the physician would be able to implement therapy for either Pseudomonas 
(excluding P. aeruginosa) or Enterobacteriaceae infection much sooner with the 
ITS-PCR result than with the results of Gram staining, which would only indicate the 
presence of Gram-negative bacteria. To differentiate strains based on ITS-PCR products, 
which revealed a similar single band, conventional phenotypic methods should be 
performed in parallel. On the other hand, four isolates were not identified, as these 
strains showed novel ITS-PCR patterns. Therefore, it is necessary to continue adding 
new ITS-PCR patterns of isolates from clinical materials to the database, resulting in 
increased sensitivity. 
 Because our PCR-based method with universal primers amplified all kinds of 
bacteria, the major limitation of our methods for the direct detection of bacteria from 
clinical samples is mixed flora. Polymicrobial bacteremia due to GNB have been 
reported in 2 of 405 (1.0%) blood culture bottles (16). In our study, 4 of 255 bottles 
(1.6% ) had two different Enterobacteriaceae identified in each sample by conventional 
methods. When electrophoresis of culture showed an unusual pattern with two or more 
fragments, the presence of mixed flora should be taken into consideration and the 
identification of bacteria may be difficult. Overall, these observations indicated that 
ITS-PCR followed by MGE is useful for rapid, cost-effective, and reliable species-level 
identification of GNB responsible for bloodstream infections. The approach described 
here seems also to be useful for the recognition of potentially novel infection-associated 
pathogens.  
In recent years, CTX-M ESBL has been recognized as a growing family possessing a 
high level of hydrolyzing activities, especially against cefotaxime. The present study 
showed that 105 (98%) of 107 ESBL-producers isolated from various clinical samples 
were CTX-M-type ESBL. The same results were reported by Suzuki et al. (23). They 
reported that 130 (92%) of 142 E. coli isolates suspected of producing ESBL were 
confirmed to harboring blaCTX-M by PCR and sequencing analysis. There are more than 
80 different variants of CTX-M enzymes, which can be further classified into five 
different subgroups based on their amino acid sequences: CTX-M-1, CTX-M-2, CTX-M-8, 
CTX-M-9, and CTX-M-25 groups (4). Of these, CTX-M-9, CTX-M1, and CTX-M-2 groups 
have been reported as the most common groups in Japan (23). In this study, the most 
common CTX-M was CTX-M-9 group (88%), followed by CTX-M-1 and CTX-M-2 group. 
The predominance of CTX-M-9 in our hospital is not a consistent finding worldwide, as 
different CTX-M-type enzymes have emerged as the predominant ESBLs in other 
locations (4). K. oxytoca may give a false-positive result in phenotypic tests for ESBL 
production due to hyperproduction of the chromosomally encoded K1 β-lactamase (20). 
Monstein et al. (17) have shown that the universal blaCTX-M PCR amplification primers 
also target the almost identical K1 DNA sequence. The same results were obtained in 
the present study. Therefore, reports regarding CTX-M ESBL production from K. 
oxytoca by PCR should be excluded until sequencing results have been determined.  
As the CTX-M gene amplicon size was very small (216 bp) and PCR products obtained 
from ITS-PCR ranged from 241 bp to 1765 bp, PCR-MGE enabled simultaneous 
detection of CTX-M gene and ITS-PCR patterns, which was both cost-effective and 
saved time. Poor outcome occurs when patients with serious infections (bacteremia, 
hospital-acquired pneumonia, peritonitis) due to ESBL-producers are treated with 
cephalosporins to which the responsible organism is resistant (12, 22). The provision of 
PCR results regarding bacterial identification and CTX-M ESBL at the initial physician 
contact could result in prudent therapy. The methods described here may also be useful 
for detecting novel CTX-M-producing species, because CTX-M-producing P. aeruginosa 
and S. maltophilia have been reported previously (1). There are epidemiological 
implications for the detection of ESBL-producers in that this resistance may not be as 
apparent if the organisms are simply reported as resistant to individual cephalosporins.         
 In conclusion, detection of the ITS length polymorphisms by PCR-MGE is useful for  
rapid, reliable, and relatively cost effective species-level identification of GNB 
responsible for bloodstream infections. In addition, PCR-MGE seems to be a useful tool 
for simultaneous detection of CTX-M ESBL and ITS-PCR patterns of GNB. The main 
limitation of ITS-PCR identification method relies on the database and on the 
inter-laboratory variations. We are preparing a database with the high integrity that 
can be applied comprehensively to pathogenic bacteria, and our database may be shared 























Sizes of amplified DNA 





























JCM 5490 T 
JCM 9659 T 
JCM 6841 T 
JCM 6842 T 
K6122 
JCM 6840 T 
 
JCM 1027 T 
 





JCM 1090 T 
K9554 
K5271 





JCM 1233 T 
JCM 5833 T 
































436 ± 1, 683 ± 4 
690 ± 4, 745 ± 6 
 
685 ± 6 
750 ± 4, 790 ± 6 
740 ± 7, 760 ± 7, 815 ± 10,  
850 ± 10, 910 ± 15 
562 ± 7, 618 ± 7, 626 ± 9, 642 ± 7, 
663 ± 8 
438 ± 3, 679 ± 5 
241 ± 2, 583 ± 8, 645 ± 7 
242 ± 3, 458 ± 3, 580 ± 4, 645 ± 8 
458 ± 3, 540 ± 3, 610 ± 3 
479 ± 8, 619 ± 5, 661 ± 5 
486 ± 1, 653 ± 4 
949 ± 8 
612 ± 4 
451 ± 1, 479 ± 2, 629 ± 2 
 
743 ± 5, 1765 ± 35 
324 ± 2, 483 ± 8, 629 ± 2 
443 ± 5, 475 ± 4, 498, 605 ± 3 
450 ± 2, 517 ± 2 
756 ± 5 
434 ± 5, 529 ± 6 
 
688 ± 5 












Sizes of amplified DNA  















































JCM 1236 T 
K5105 
JCM 1669 T 
 
K7446 
JCM 1668 T 
 
JCM 1673 T  




JCM 5967 T 
 
JCM 5968 T 






























pps (2)  
pfl (6) 
294 ± 5, 440 ± 6, 591 ± 6 
295 ± 4, 441 ± 6, 529 ± 6,  
292 ± 4, 438 ± 7, 526 ± 7, 593 ± 8, 
422 ± 1, 444 ± 4, 455 ± 5, 478 ± 5, 
529 ± 4, 540 ± 4, 553 ± 2 
578 ± 5, 681 ± 2, 766 ± 3, 793 ± 5, 
825 ± 9, 854 ± 8 
290 ± 4, 311 ± 3, 439 ± 5, 467 ± 5, 520 
± 5, 591 ± 7 
315 ± 2, 477 ± 5, 623 ± 3 
293 ± 3, 439 ± 4, 590 ± 5 
451 ± 2, 569 ± 6, 591 ± 7, 775 ± 10 
562 ± 2, 586 ± 3, 744 ± 4, 778 ± 6 
589 ± 9, 760 ± 6, 779 ± 6 
732 ± 7 
470 ± 1, 487 ± 3, 674 ± 6 
498 ± 3, 716 ± 4 
501 ± 6, 622 ± 5, 647 ± 7, 674 ± 8 
830 ± 7 
629 ± 7, 659 ± 5, 689 ± 4, 820 ± 9 
608 ± 3, 633 ± 7, 657 ± 2, 784 ± 4 
812 ± 5, 865 ± 3 
514 ± 5, 672 ± 8 
702 ± 8, 732 ± 10, 756 ± 4, 787 ± 3 
819 ± 8, 890 ± 12 
670 ± 5, 761 ± 9 
318 ± 3, 560 ± 4 
576 ± 4 
 
606 ± 3 












Sizes of amplified DNA  



















JCM 5969 T 
ATCC 14028 





JCM 1277 T 
 
JCM 1976 
JCM 1975 T 
















374 ± 6, 383 ± 1, 558 ± 2, 595 ± 6 
401 ± 3, 589 ± 3 
591 ± 3 
594 ± 7 
449 ± 4, 512 ± 5, 624 ± 4 
501 ± 4, 568 ± 5 
504 ± 4, 547 ± 1, 568 ± 3 
548 ± 3, 566 ± 3 
546 ± 4, 564 ±6, 615 ± 3 
 
474 ± 4 
 
606 ± 8, 627 ±5, 647 ± 6 
624 ± 5, 
540 ± 3, 601 ± 3, 661 ± 4, 787 ± 9 
 a Mean amplicon sizes were obtained from the results of three experiments for each 
control strain. The underlines indicate the sharp and intense fragments that were 
consistently observed. 
b Acinetobacter calcoaceticus-baumannii complex included two reference strains, 
Acinetobacter calcoaceticus JCM6841T and Acinetobacter baumannii JCM6842T. 
 cITS-PCR patterns of Enterobacter aerogenes strains and some Enterobacter cloacae 
strains were similar to those of Klebsiella oxytoca.  
 d Nine strains of the genus Salmonella included six serotypes, S. Paratyphi A, S.    
 Paratyphi B, S. Choleraesuis, S. Typhimurium, S. Typhi, and S. Enteritidis.  
 
 
TABLE 2．Results of ITS-PCR analysis and extended-spectrum β-lactamase  
PCR with positive blood culture bottles for Gram-negative bacteria 
  
Organism 
(total no. of bottlea) 
No. (%) of strains 
identified correctly 
at species level by 
ITS-PCR patterns 
No. (％) of the  
CTX-M ESBL-  
producing isolates  
                 
  
E. coli (104) 
P. aeruginosa (30) 
K. pneumoniae (29) 
S. maltophilia (18) 
E. cloacae (12) 
K. oxytoca (10) 
S. marcescens (8) 
A. calcoaceticus- 
   baumannii complex (6) 
B. fragilis (6) 
E. aerogenes (6) 
A. xylosoxidans (4) 
C. koseri (4) 
C. freundii (3) 
P. mirabilis (3) 
H. influenzae (2) 
A. lwoffii (2) 
B. cepacia (1) 
E. tarda (1) 
N. meningitidis (1) 
P. putida (1) 
Polymicrobial (4) 
 
     Total (255) 
104 (100)        
30 (100)         
29 (100)         
18 (100)         
6 (50)b         
0 (0) b         
8 (100)         
 
6 (100)         
3 (50)          
0 (0)b         
4 (100)          
4 (100)         
3 (100)         
3 (100)  
2 (100) 
     1 (50)           
     1 (100)         
     1 (100)         
     1 (100)         




   20 (19) 
    0 
    0 
    0 
    0 
    0 
    0 
    0 
    0 
    0 
    0 
    0 
    0 
    0 
    0 
    0 
    0 
    0 
    0 
    0 
    0 
    0 
 
   20 (19) 
a When two or more samples obtained from the same patient were positive for the 
same organism, only one sample was included.  
b Six E. cloacae isolates and six E. aerogenes isolates showed similar ITS-PCR 
patterns to those of K. oxytoca. Therefore, the isolates revealed the ITS-PCR 













































FIG. 1. Results of microchip gel electrophoresis of ITS-PCR products of clinically 
relevant Gram-negative organisms in positive blood cultures (A), and the simultaneous 
detection of PCR products of CTX-M ESBL gene and ITS regions obtained from E. coli 
K2588 (B). Asterisk indicates PCR product (216 bp) of the CTX-M ESBL gene, and 
arrows indicate DNA size markers of 100 bp (left) and 1,000bp (right). Int., Intensity. 
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